Quantcast
Last updated on April 18, 2014 at 9:25 EDT

100% Refund Program at Midwest Fertility Provides Peace of Mind for IVF Patients

September 19, 2013

Fertility experts at Midwest Fertility Specialists in Carmel, Indiana announced today they have launched a 100% refund program for in-vitro fertilization (IVF) patients.

Carmel, Indiana (PRWEB) September 19, 2013

The Attain® IVF 100% refund program at Midwest Fertility offers patients a full course of treatment for a single, discounted fee and a refund if unsuccessful.

Qualified patients, 35 and under, are guaranteed up to a 100% refund of their program fee if they do not take home a baby after six tries. Midwest Fertility is the exclusive provider of this refund program in Indiana and surrounding states.

"Success for our patients means taking home a baby, but cost can be a factor in deciding to pursue IVF," said Dr. Laura Reuter, Reproductive Endocrinologist and Medical Director at Midwest Fertility Specialists. "By committing to this course of treatment plan, patients can save thousands of dollars." Reuter added, "92 percent of patients who participate in the Attain IVF 100% Refund Program take home a baby. That’s very reassuring to patients who are dealing with infertility."

Additional Attain IVF Programs are available at Midwest Fertility, including an option for patients who do not meet the medical criteria. About 75% of patients, however, qualify for a refund program.

The Attain IVF Programs are offered exclusively at Midwest Fertility and other select centers in the Attain IVF Network. Physicians accepted into this network must pass a rigorous review process and be approved for participation by Attain IVF’s Council of Physicians and Scientists.

More about Midwest Fertility Specialists

Midwest Fertility Specialists specializes in the treatment of infertility. With office locations in Carmel, Noblesville, and Ft. Wayne, IN as well as Champaign, IL our team of Reproductive Endocrinologists offer a wide range of infertility treatments from ovulation induction and intrauterine insemination (IUI) to the most advanced assisted reproductive technologies including in-vitro fertilization (IVF), egg donation, pre-implantation genetic diagnosis (PGD) and more. Midwest Fertility Specialists offers individualized infertility treatment plans in a patient-focused and supportive environment. Support services such as psychological counseling and acupuncture are also available through Midwest Fertility Specialists’ Complimentary Medicine Program, as well as infertility treatment financing.

The Midwest Fertility Specialists’ team of physicians includes Drs. Bradford Bopp, Robert Colver, Laura Reuter, and Matthew Will. Glen Adaniya, Ph.D., is the Lab Director. All doctors are members of the American Society for Reproductive Medicine (ASRM) and the Society for Assisted Reproductive Technology (SART). Midwest Fertility Specialists is accredited by the Accreditation Association for Ambulatory Health Care (AAAHC). The IVF and Andrology/Endocrinology labs are accredited by the Joint Commission and Clinical Laboratory Improvement Amendments (CLIA). For more information visit http://www.midwestfertility.com.

More about Attain® IVF

The Attain® IVF Programs are offered exclusively at practices that are members of IntegraMed Fertility's Attain® IVF Fertility Network. The network is comprised of 38 centers at 149 locations across 31 states and the District of Columbia. Fertility's consumer brand, Attain® IVF Fertility, provides fertility patients information and support through its website and social media communities.

IntegraMed® Fertility is a division of IntegraMed America, Inc., a leader in developing, marketing and managing specialty outpatient healthcare facilities, with a current focus on the fertility and vein care markets. IntegraMed Fertility supports its provider networks with clinical and business information systems, marketing and sales, facilities and operations management, finance and accounting, human resources, legal, risk management, quality assurance, and fertility treatment financing programs.

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/9/prweb11131198.htm


Source: prweb